OKLAHOMA CITY, OK, AUSTIN, TX, LOOS, FRANCE  --  Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with Innobiochips (IBC), a developer of innovative immunoassays and the SirYus™ diagnostic platform technology, to develop personalized HLA diagnostics that will detect and quantify donor specific antibodies (DSA’s) in post-transplant settings and provide the basis for post-transplant monitoring and early detections of transplant rejection.